Prevention of respiratory distress syndrome by antenatal maternal steroid treatment

I. Horvath, K. Mehes, I. Fias, Sz Szmodits

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A total of 107 women at risk of premature delivery received antepartum 45 to 60 mg prednisolone medication. Their babies were matched with comparable neonates of untreated mothers. The frequency of respiratory distress syndrome was 6/107 in the steroid-treated, and 33/107 in the control group. No maternal complications were seen. Neonatal mortality was lower in the pretreated group in which, however, a higher number of bronchopneumonia was observed. In 58 prednisolone-treated women labour could be delayed, and their infants were born at term. No stillbirth or intrauterine growth retardation occurred among them.

Original languageEnglish
Pages (from-to)303-306
Number of pages4
JournalActa paediatrica Academiae Scientiarum Hungaricae
Volume17
Issue number4
Publication statusPublished - Dec 1 1976

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Prevention of respiratory distress syndrome by antenatal maternal steroid treatment'. Together they form a unique fingerprint.

  • Cite this